Targeted Contrast-enhanced Ultrasound Imaging of Tumor Angiogenesis with Contrast Microbubbles Conjugated to Integrin-binding Knottin Peptides
Overview
Authors
Affiliations
Unlabelled: Targeted contrast-enhanced ultrasound imaging is increasingly being recognized as a powerful imaging tool for the detection and quantification of tumor angiogenesis at the molecular level. The purpose of this study was to develop and test a new class of targeting ligands for targeted contrast-enhanced ultrasound imaging of tumor angiogenesis with small, conformationally constrained peptides that can be coupled to the surface of ultrasound contrast agents.
Methods: Directed evolution was used to engineer a small, disulfide-constrained cystine knot (knottin) peptide that bound to alpha(v)beta(3) integrins with a low nanomolar affinity (Knottin(Integrin)). A targeted contrast-enhanced ultrasound imaging contrast agent was created by attaching Knottin(Integrin) to the shell of perfluorocarbon-filled microbubbles (MB-Knottin(Integrin)). A knottin peptide with a scrambled sequence was used to create control microbubbles (MB-Knottin(Scrambled)). The binding of MB-Knottin(Integrin) and MB-Knottin(Scrambled) to alpha(v)beta(3) integrin-positive cells and control cells was assessed in cell culture binding experiments and compared with that of microbubbles coupled to an anti-alpha(v)beta(3) integrin monoclonal antibody (MB(alphavbeta3)) and microbubbles coupled to the peptidomimetic agent c(RGDfK) (MB(cRGD)). The in vivo imaging signals of contrast-enhanced ultrasound with the different types of microbubbles were quantified in 42 mice bearing human ovarian adenocarcinoma xenograft tumors by use of a high-resolution 40-MHz ultrasound system.
Results: MB-Knottin(Integrin) attached significantly more to alpha(v)beta(3) integrin-positive cells (1.76 +/- 0.49 [mean +/- SD] microbubbles per cell) than to control cells (0.07 +/- 0.006). Control MB-Knottin(Scrambled) adhered less to alpha(v)beta(3) integrin-positive cells (0.15 +/- 0.12) than MB-Knottin(Integrin). After blocking of integrins, the attachment of MB-Knottin(Integrin) to alpha(v)beta(3) integrin-positive cells decreased significantly. The in vivo ultrasound imaging signal was significantly higher after the administration of MB-Knottin(Integrin) than after the administration of MB(alphavbeta3) or control MB-Knottin(Scrambled). After in vivo blocking of integrin receptors, the imaging signal after the administration of MB-Knottin(Integrin) decreased significantly (by 64%). The imaging signals after the administration of MB-Knottin(Integrin) were not significantly different in the groups of tumor-bearing mice imaged with MB-Knottin(Integrin) and with MB(cRGD). Ex vivo immunofluorescence confirmed integrin expression on endothelial cells of human ovarian adenocarcinoma xenograft tumors.
Conclusion: Integrin-binding knottin peptides can be conjugated to the surface of microbubbles and used for in vivo targeted contrast-enhanced ultrasound imaging of tumor angiogenesis. Our results demonstrate that microbubbles conjugated to small peptide-targeting ligands provide imaging signals higher than those provided by a large antibody molecule.
Courcier J, Leguerney I, Benatsou B, Pochon S, Tardy I, Albiges L Int J Mol Sci. 2023; 24(22).
PMID: 38003400 PMC: 10671137. DOI: 10.3390/ijms242216211.
Bubble-Based Drug Delivery Systems: Next-Generation Diagnosis to Therapy.
Kancheva M, Aronson L, Pattilachan T, Sautto F, Daines B, Thommes D J Funct Biomater. 2023; 14(7).
PMID: 37504868 PMC: 10382061. DOI: 10.3390/jfb14070373.
Keller C, Zarkesh S, Zhou J, Lutz A, Hristov D, Kamaya A Sci Rep. 2023; 13(1):1686.
PMID: 36717575 PMC: 9886917. DOI: 10.1038/s41598-022-26273-0.
Hexapeptides from mammalian inhibitory hormone hunt activate and inactivate nematode reproduction.
Hart J, Mohan S, Davies K, Ferneyhough B, Clarke I, Hunt J PLoS One. 2022; 17(12):e0278049.
PMID: 36454864 PMC: 9714824. DOI: 10.1371/journal.pone.0278049.
Whitaker R, Decano J, Gormley C, Beigie C, Meisel C, Tan G Theranostics. 2022; 12(18):7646-7667.
PMID: 36451861 PMC: 9706579. DOI: 10.7150/thno.78454.